Wednesday, February 26, 2020 4:22:21 PM
After hours, maa man!
Recent GNPX News
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 09:34:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2026 11:03:51 AM
- Genprex Collaborators to Present Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2026 AACR Annual Meeting • PR Newswire (US) • 03/18/2026 11:00:00 AM
- Genprex to Participate at BIO Europe Spring 2026 • PR Newswire (US) • 03/10/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 11:33:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2026 01:08:16 PM
- Genprex Strengthens Intellectual Property Portfolio with Japanese and EU Patents for Reqorsa® Gene Therapy in Combination with Immunotherapies to Treat Cancer • PR Newswire (US) • 02/23/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/10/2026 01:04:05 PM
- Genprex Announces IP Australia's Intent to Grant Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers • PR Newswire (US) • 02/10/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2026 09:58:44 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 01/09/2026 09:56:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/07/2026 12:04:34 PM
- Genprex Provides Clinical Update on Diabetes Gene Therapy Program • PR Newswire (US) • 01/07/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/06/2026 12:03:02 PM
- Genprex Announces Positive Preliminary Preclinical Data from Study of GPX-002 in Type 2 Diabetic Animal Studies • PR Newswire (US) • 01/06/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/23/2025 10:35:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/23/2025 10:35:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/23/2025 10:34:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/23/2025 10:31:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/23/2025 12:15:48 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/12/2025 09:41:19 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/26/2025 09:31:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/26/2025 01:01:07 PM
